Fintel reports that on March 20, 2025, William Blair downgraded their outlook for Beacon Roofing Supply (NasdaqGS:BECN) from ...

Equities researchers at William Blair issued their Q1 2026 earnings per share (EPS) estimates for Genmab A/S in a research note issued on Tuesday, March 18th. William Blair analyst M. Phipps ...

Equities researchers at William Blair issued their Q4 2026 earnings estimates for argenx in a report released on Monday, ...

Fintel reports that on March 17, 2025, William Blair initiated coverage of Butterfly Network (NYSE:BFLY) with a Outperform ...

Incyte (NASDAQ:INCY – Get Free Report) was downgraded by William Blair from an “outperform” rating to a “market perform” rating in a note issued to investors on Tuesday, Marketbeat.com reports.

US President Donald Trump has imposed a 25 % tariff on Canada’s steel and aluminium and has threatened sweeping tariffs on ...

Equities researchers at William Blair issued their Q1 2026 EPS estimates for shares of Science Applications International in ...

We recently compiled a list of the 10 AI Stocks Investors Are Watching Closely Right Now. In this article, we are going to ...

Fintel reports that on March 17, 2025, William Blair upgraded their outlook for DocuSign (NasdaqGS:DOCU) from Market Perform ...

Fintel reports that on March 18, 2025, William Blair downgraded their outlook for Incyte (NasdaqGS:INCY) from Outperform to Market Perform. Analyst Price Forecast Suggests 28.39% Upside As of March 4, ...

Analysts at William Blair lowered their Q1 2025 earnings estimates for Legend Biotech in a research report issued to clients ...

Research analysts at William Blair issued their Q1 2026 earnings estimates for shares of argenx in a research note issued on ...